Nanobiotix S.A.
Price Action
Technical Summary
STAGE 2 UPTRENDNanobiotix S.A. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings growth of 76% provides fundamental context to the price action. However, price is extended 30% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $33.76 | +26.22% | ABOVE |
| 50 SMA | $32.79 | +29.95% | ABOVE |
| 100 SMA | $27.66 | +54.07% | ABOVE |
| 150 SMA | $25.69 | +65.88% | ABOVE |
| 200 SMA | $21.68 | +96.53% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is NBTX in an uptrend right now?
NBTX has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, NBTX is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is NBTX overbought or oversold?
NBTX's RSI (14) is 68. The stock is in neutral territory, neither overbought nor oversold.
Is NBTX outperforming the market?
NBTX has a Relative Strength (RS) Rating of 94 out of 99. Yes, NBTX is a market leader, outperforming 94% of all stocks over the past 12 months.
Where is NBTX in its 52-week range?
NBTX is trading at $42.61, which is 96% of its 52-week high ($44.46) and 96% above its 52-week low ($3.26).
How volatile is NBTX?
NBTX has a Beta of 1.81 and 52-week volatility of 105%. It's more volatile than the S&P 500 - expect bigger swings.